Join our team
SAiGENCI is growing. The Institute has recruited some remarkable cancer research talent to Adelaide.
Leadership team
- Professor Christopher Sweeney - Director
- Professor Lisa Butler - Program Lead, Resistance Prevention
- Professor Brendan Jenkins - Program Lead, Tumour Inflammation and Immunotherapy
- Professor Jose Polo - Program Lead, Cancer Epigenetics and Director of the Adelaide Centre for Epigenetics
Work with us
SAiGENCI Group Leaders are working on staffing their teams across all four of our exciting research programs.
- Cancer Epigenetics - striving to unravel the epigenetic mechanisms contributing to cancer, with the aim of developing effective therapeutics.
- Computational Systems Oncology – bringing high-density data from the clinic and laboratories into one integrated environment and interrogating it to produce new insights about where and why cancer appears and progresses.
- Resistance Prevention – exploring, explaining and preventing resistance to cancer therapies, including:
- Hormone Dependent Cancers - with a focus on prostate and breast cancer, and
- Paediatric and Neuro-oncology - focussing on the unique aspects of paediatric cancer as well as adult and paediatric brain tumours.
- Tumour Inflammation and Immunotherapy – developing strategies to harness the immune system to tackle cancers.
Opportunities to join SAiGENCI are regularly advertised via the University of Adelaide's Job Opportunities website.
Join our Consumer Advisory Group
We are seeking consumers and community members with an interest in; or lived experience with cancer to join our new SAiGENCI Consumer Advisory Group.
Living in Adelaide
Adelaide is the third most liveable city in the world* and home to world-class health care and medical research. Get to know more about living and working in Adelaide and our partners:
*The Economist Intelligence Unit's Global Liveability Index 2021
